ENTITY

Sunho Biologics (SHB HK)

4
Analysis
Health CareChina

bearishSunho Biologics
25 Apr 2024 08:55

Pre-IPO Sunho Biologics (PHIP Updates) - Some Points Worth the Attention

​Sunho's high-risk pipeline makes future return highly uncertain. Reorganization with related parties and "sudden" capital increase raised concern...

Logo
288 Views
Share
bearishSunho Biologics
30 Nov 2023 17:21

Sunho Biologics (盛禾) Pre-IPO: Testing the Unproven Targets

We examine the fundamentals of Sunho Biologics for its IPO. We are not positive on the success of its product pipeline and are not impressed with...

Logo
204 Views
Share
bearishTYK Medicines
24 Jul 2024 08:55

Pre-IPO TYK Medicines (PHIP Updates) - Some Points Worth the Attention

​TYK has differentiated indication for core product, but it faces uncertainty in R&D. Cash shortage is an issue. We recommend a more cautious...

Logo
322 Views
Share
bearishSunho Biologics
24 Aug 2023 08:55

Pre-IPO Sunho Biologics (SHB HK) - High Valuations Can Be Hard to Come By

Sunho does not have any drugs at NDA/BLA stage or commercialized products. Its outlook is highly uncertain due to challenging clinical trials...

Logo
351 Views
Share
No more insights
x